[Lessons learned from differentiation therapy with all-trans retinoic acid in the JALSG APL studies].
Asou
Norio
N
D000970:Antineoplastic Agents / Q000494:pharmacology / Q000627:therapeutic use*; D006801:Humans; D015473:Leukemia, Promyelocytic, Acute / Q000188:drug therapy*; D014212:Tretinoin / Q000494:pharmacology / Q000627:therapeutic use*
D000970:Antineoplastic Agents; D014212:Tretinoin